预测(人工智能)
医学
胰高血糖素样肽-1
消费(社会学)
受体
胰高血糖素
奖励制度
神经科学
内分泌学
内科学
胰岛素
糖尿病
2型糖尿病
心理学
人工智能
计算机科学
社会科学
社会学
作者
Liselotte van Bloemendaal,Dick J. Veltman,Jennifer S. ten Kulve,P.F.C. Groot,Henricus G. Ruhé,Frederik Barkhof,John H. Sloan,M. Diamant,Richard G. IJzerman
摘要
Aim To test the hypothesis that food intake reduction after glucagon‐like peptide‐1 ( GLP ‐1) receptor activation is mediated through brain areas regulating anticipatory and consummatory food reward. Methods As part of a larger study, we determined the effects of GLP ‐1 receptor activation on brain responses to anticipation and receipt of chocolate milk versus a tasteless solution, using functional MRI ( fMRI ). Obese subjects with type 2 diabetes, and obese and lean subjects with normoglycaemia (n = 48) underwent three fMRI sessions at separate visits with intravenous infusion of the GLP ‐1 receptor agonist exenatide, exenatide with prior GLP ‐1 receptor blockade by exendin‐9‐39 or placebo, during somatostatin pituitary‐pancreatic clamps. Results Body mass index negatively correlated with brain responses to receipt of chocolate milk and positively correlated with anticipation of receipt of chocolate milk in brain areas regulating reward, appetite and motivation. Exenatide increased brain responses to receipt of chocolate milk and decreased anticipation of receipt of chocolate milk compared with placebo, paralleled by reductions in food intake. Exendin‐9‐39 largely prevented these effects. Conclusions Our findings show that GLP ‐1 receptor activation decreases anticipatory food reward, which may reduce cravings for food and increases consummatory food reward, which may prevent overeating.
科研通智能强力驱动
Strongly Powered by AbleSci AI